Natera has announced that DiagCor has signed an agreement to launch Natera's Panorama non-invasive prenatal screening test, or NIPT, in Hong Kong. Panorama uses a simple blood draw from the mother to detect trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), monosomy X (Turner's syndrome), triploidy (Triploid syndrome) and sex chromosome aneuploidies. The test, launched in the US, is highly accurate and can be performed from nine weeks onward.